Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Malaria Vaccines
Recent findings from D.C. Kaushal and co-authors highlight research in malaria vaccines
May 14th, 2008
"Plasmodium vivax is one of the most widely distributed human malaria parasites and due to drug-resistant strains, its incidence and prevalence has increased, thus an effective vaccine against the parasites is urgently needed. One of the major constraints in developing P: vivax vaccine is the lack of suitable in vivo models for testing the protective efficacy of the vaccine. P. vivax and P. cynomolgi bastianelli are the two closely related malaria parasites and share a similar clinical course of infection in their respective hosts," scientists in Lucknow, India report. "The merozoite surface protein-1 (MSP-1) of these parasites has found to be protective in a wide range...
Source: Vaccine Weekly (2008-05-14)
|
